Clinical Trial Update: Basal Analog Study - Comparison of Lantus or Levemir With NPH Insulin From T1DM Diagnosis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update comparing basal insulin analogs Lantus and Levemir with NPH insulin in people with Type 1 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Lantus (insulin glargine)
• Levemir (insulin detemir)
• NPH insulin (insulin isophane)

Snippet

Sponsor: Karolinska Institutet | Conditions: Diabetes Mellitus Type 1 | Phase 4 | Status: UNKNOWN